Phantomics, a leader in medical artificial intelligence(AI), announced that it has won the CES 2024 Innovation Award for its medical imaging AI technology.
Phantomics received the award for its medical AI solution, "Myomics." Myomics is a non-invasive heart MRI imaging analysis technology that enables early diagnosis of heart disease, providing accuracy comparable to tissue biopsy.
The technology significantly reduces the image analysis time from 30 minutes to under 2 minutes, minimizing errors in results across different hospitals and enabling the standardization of analysis.
Pan Ki Kim and Byoung Wook Choi, co-CEOs of Phantomics, stated, "This will greatly contribute to the early diagnosis of heart diseases, such as sudden cardiac death." They added, "With over 20 years of clinical experience in cardiovascular imaging and excellent research and development capabilities, we are continuing to develop this technology and will provide cutting-edge AI solutions in the future."
Read Article
Phantomics, a leader in medical artificial intelligence(AI), announced that it has won the CES 2024 Innovation Award for its medical imaging AI technology.
Phantomics received the award for its medical AI solution, "Myomics." Myomics is a non-invasive heart MRI imaging analysis technology that enables early diagnosis of heart disease, providing accuracy comparable to tissue biopsy.
The technology significantly reduces the image analysis time from 30 minutes to under 2 minutes, minimizing errors in results across different hospitals and enabling the standardization of analysis.
Pan Ki Kim and Byoung Wook Choi, co-CEOs of Phantomics, stated, "This will greatly contribute to the early diagnosis of heart diseases, such as sudden cardiac death." They added, "With over 20 years of clinical experience in cardiovascular imaging and excellent research and development capabilities, we are continuing to develop this technology and will provide cutting-edge AI solutions in the future."
Read Article